Companies: 10,795·Total market cap: $144.5T
MedinCell S.A.

MedinCell S.A.

MDCLFOTCHealthcare● Active
$34.39
+$0.00(+0.00%)
Market Cap$1.2B
P/E Ratio
52W High$34.39
52W Low$6.9757
Overview

MedinCell S.A. (MDCLF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

MDCLF · net income · updated Jun 9, 2026

Core profitability metrics

Net income was −$18.4M for FY2025 (fiscal year ending 2025-03-31), up 26.4% year-over-year. Net profit margin was -72.2%. Based on available data, MedinCell S.A. has been profitable since at least 2016.

FY2025 Net Income−$18.4M▲ +26.4% YoY
Trailing 12M (TTM)−$51.3Mtrailing 4 quarters sum
Net Profit Margin-72.2%−$18.4M ÷ $25.5M
YoY Change+26.4%
5-Year CAGRN/AN/A — contains loss years
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net IncomeNet LossNet Margin %★ First Profit: 2016

▸ FMP /income-statement · Annual · MDCLF net income history · MDCLF profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2025Loss−$18.4M▲ +26.4%-72.2%
FY2024Loss−$25.0M▲ +21.8%-273.3%
FY2023Loss−$32.0M▼ 29.0%-321.9%
FY2022Loss−$24.8M▼ 30.4%-606.5%
FY2021Loss−$19.0M▲ +20.5%-232.3%

Net income vs peers (Healthcare)

#CompanyNet IncomeYoY
#1
MedinCell S.A.
MedinCell S.A.YOU
MDCLF
−$18.4M+26.4%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$26.80B+90.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$20.64B+94.9%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$12.06B-16.3%
#5
AbbVie Inc.
AbbVie Inc.
ABBV
$4.23B-1.2%
Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

MedinCell S.A. (MDCLF) reported net income of −$18.4M for FY2025 (fiscal year ending 2025-03-31), up 26.4% year-over-year. The net profit margin was -72.2% — meaning the company kept $-0.72 of every dollar of revenue as profit.

Based on available data, MedinCell S.A. has been profitable since at least 2016. Net income reached a peak of $622,000 in FY2016. Data available for 10 fiscal years.

MedinCell S.A.'s net profit margin was -72.2% for FY2025, based on the latest annual results.

Investors sometimes search for "MedinCell S.A. net worth" — the company's market capitalization is a separate figure from MDCLF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Frequently asked questions

MDCLF net income · 4 questions

MedinCell S.A. is not currently profitable on an annual basis. The company reported a net loss of $18.4M for FY2025.

is MDCLF profitabledoes MDCLF make a profitMDCLF profitabilityMDCLF profitable company

Source: FMP /income-statement · GAAP · MedinCell S.A. · MedinCell S.A. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026